Assertio Holdings, Inc. Announces Closing of Registered Direct Offering of $14 Million
09 févr. 2021 16h05 HE
|
Assertio Holdings, Inc.
LAKE FOREST, Ill., Feb. 09, 2021 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (NASDAQ: ASRT) today announced that it closed its previously announced registered direct of...
Assertio Holdings, Inc. Announces Pricing of $14 Million Registered Direct Offering
05 févr. 2021 00h05 HE
|
Assertio Therapeutics, Inc.
LAKE FOREST, Ill., Feb. 05, 2021 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (NASDAQ: ASRT) today announced it has entered into a securities purchase agreement with...
Assertio Announces $5.0 Million Insurance Settlement and General Corporate Updates
03 févr. 2021 16h01 HE
|
Assertio Therapeutics, Inc.
LAKE FOREST, Ill., Feb. 03, 2021 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT) today announced that its subsidiary Assertio Therapeutics, Inc. (“Assertio...
Assertio Announces Transfer of Listing from Nasdaq Global Select Market to Nasdaq Capital Market
29 déc. 2020 16h05 HE
|
Assertio Therapeutics, Inc.
Company Receives additional 180-day grace period, until June 28, 2021, to satisfy the $1.00 bid price requirement to maintain Nasdaq listing Trading on Nasdaq Capital Market is expected to begin on...
Assertio Announces Restructuring Plan and Leadership Changes
15 déc. 2020 09h00 HE
|
Assertio Therapeutics, Inc.
LAKE FOREST, Ill., Dec. 15, 2020 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT) today announced a comprehensive restructuring plan designed to further...
Assertio to Present at the Stifel 2020 Virtual Healthcare Conference on November 17, 2020
10 nov. 2020 16h01 HE
|
Assertio Therapeutics, Inc.
LAKE FOREST, Ill., Nov. 10, 2020 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT), a commercial-stage pharmaceutical company, announced that President, chief...
Assertio Reports Third Quarter 2020 Financial Results
06 nov. 2020 06h00 HE
|
Assertio Therapeutics, Inc.
Reported Net Product Sales of $34.3 Million Non-GAAP Net Product Sales of $33.7 Million; Increased 21.4% over Pro-Forma Second Quarter 2020 Non-GAAP Net Product Sales...
Assertio to Release Third Quarter 2020 Financial Results and Host Webcast on November 6, 2020
23 oct. 2020 08h00 HE
|
Assertio Therapeutics, Inc.
LAKE FOREST, Ill., Oct. 23, 2020 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT), a commercial-stage pharmaceutical company, today announced that its third...
Assertio to Present at Cantor Virtual Global Healthcare Conference on September 16, 2020
09 sept. 2020 06h02 HE
|
Assertio Therapeutics, Inc.
LAKE FOREST, Ill., Sept. 09, 2020 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT), a commercial-stage pharmaceutical company, announced that the company will...
Assertio Reports Second Quarter 2020 Financial Results
07 août 2020 06h02 HE
|
Assertio Therapeutics, Inc.
--Completed all merger and integration activities in Q2----Repaid $10 million of Senior Secured Notes ahead of schedule-- --Zyla products partially contributed to Q2 net product sales of $20.2...